Regulation of chromatin structure in the cardiovascular system

Circulation Journal

Volumn 77, Issue 6, 2013, Pages 1389-1398

  Rosa Garrido, Manuel ^a   Karbassi, Elaheh ^a   Monte, Emma ^a   Vondriska, Thomas M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heart failure; Hypertension; Myocardial ischemia

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DNA (CYTOSINE 5) METHYLTRANSFERASE; HISTONE H2AZ; HISTONE METHYLTRANSFERASE; METHYL CPG BINDING PROTEIN 2; MICRORNA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR TBX5; UNTRANSLATED RNA;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL INTERACTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; GENE ACTIVATION; GENE SILENCING; HISTONE MODIFICATION; HUMAN; MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; HUMANS;

EID: 84878253919     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0176     Document Type: Review

References (109)

1. Richmond TJ, Davey CA. The structure of DNA in the nucleosome core. Nature 2003; 423: 145-150.
2. Nair AP, Timoh T, Fuster V. Contemporary medical management of systolic heart failure. Circ J 2012; 76: 268-277.
3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2013 Update: A report from the American Heart Association. Circulation 2013; 127: e6-e245.
4. Young NL, DiMaggio PA, Plazas-Mayorca MD, Baliban RC, Floudas CA, Garcia BA. High throughput characterization of combinatorial histone codes. Mol Cell Proteomics 2009; 8: 2266-2284.
5. Siuti N, Kelleher NL. Decoding protein modifications using top-down mass spectrometry. Nat Methods 2007; 4: 817-821.
6. Garcia BA, Pesavento JJ, Mizzen CA, Kelleher NL. Pervasive combinatorial modification of histone H3 in human cells. Nat Methods 2007; 4: 487-489.
7. Nakayama J, Rice JC, Strahl BD, Allis CD, Grewal SI. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 2001; 292: 110-113.
8. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002; 298: 1039-1043.
9. Strahl BD, Ohba R, Cook RG, Allis CD. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci USA 1999; 96: 14967-14972.
10. Koch CM, Andrews RM, Flicek P, Dillon SC, Karaoz U, Clelland GK, et al. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res 2007; 17: 691-707.
11. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 2010; 107: 21931-21936.
12. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, Ahringer J. Differential chromatin marking of introns and expressed exons by H3K36 me3. Nat Genet 2009; 41: 376-381.
13. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 1998; 12: 599-606.
14. Talbert PB, Henikoff S. Histone variants: Ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol 2010; 11: 264-275.
15. Ramakrishnan V. Histone H1 and chromatin higher-order structure. Crit Rev Eukaryotic Gene Express 1997; 7: 215-230.
16. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000; 403: 41-45.
17. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011; 473: 43-49.
18. Filion GJ, van Bemmel JG, Braunschweig U, Talhout W, Kind J, Ward LD, et al. Systematic protein location mapping reveals five principal chromatin types in Drosophila cells. Cell 2010; 143: 212-224.
19. Haberland M, Montgomery RL, Olson EN. The many roles of his-tone deacetylases in development and physiology: Implications for disease and therapy. Nat Rev Genet 2009; 10: 32-42.
20. Paige SL, Thomas S, Stoick-Cooper CL, Wang H, Maves L, Sandstrom R, et al. A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell 2012; 151: 221-232.
21. Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson KE, et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 2012; 151: 206-220.
22. Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, Kuan S, et al. A map of the cisregulatory sequences in the mouse genome. Nature 2012; 488: 116-120.
23. Kaneda R, Takada S, Yamashita Y, Choi YL, Nonaka-Sarukawa M, Soda M, et al. Genome-wide histone methylation profile for heart failure. Genes Cells 2009; 14: 69-77.
24. Vermeulen M, Eberl HC, Matarese F, Marks H, Denissov S, Butter F, et al. Quantitative interaction proteomics and genome-wide pro-fling of epigenetic histone marks and their readers. Cell 2010; 142: 967-980.
25. Franklin S, Chen H, Mitchell-Jordan S, Ren S, Wang Y, Vondriska TM. Quantitative analysis of the chromatin proteome in disease reveals remodeling principles and identifies high mobility group protein B2 as a regulator of hypertrophic growth. Mol Cell Pro-teomics 2012; 11: M111.014258, doi:10.1074/mcp.M111.014258.
26. Chen IY, Lypowy J, Pain J, Sayed D, Grinberg S, Alcendor RR, et al. Histone H2A.z is essential for cardiac myocyte hypertrophy but opposed by silent information regulator 2alpha. J Biol Chem 2006; 281: 19369-19377.
27. Fedele M, Fidanza V, Battista S, Pentimalli F, Klein-Szanto AJ, Visone R, et al. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res 2006; 66: 2536-2543.
28. Cooper DN, Taggart MH, Bird AP. Unmethylated domains in vertebrate DNA. Nucl Acids Res 1983; 11: 647-658.
29. Bird A, Taggart M, Frommer M, Miller OJ, Macleod D. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 1985; 40: 91-99.
30. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196: 261-282.
31. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specifc CpG island shores. Nat Genet 2009; 41: 178-186.
32. Nikitina T, Shi X, Ghosh RP, Horowitz-Scherer RA, Hansen JC, Woodcock CL. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol Cell Biol 2007; 27: 864-877.
33. Newell-Price J, Clark AJ, King P. DNA methylation and silencing of gene expression. Trends Endocrinol Metab 2000; 11: 142-148.
34. Xie L, Weichel B, Ohm JE, Zhang K. An integrative analysis of DNA methylation and RNA-Seq data for human heart, kidney and liver. BMC Syst Biol 2011; 5(SUPPL. 3): S4.
35. Yoder JA, Soman NS, Verdine GL, Bestor TH. DNA (cytosine-5)-methyltransferases in mouse cells and tissues: Studies with a mechanism-based probe. J Mol Biol 1997; 270: 385-395.
36. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99: 247-257.
37. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9: 2395-2402.
38. Johnson R, Richter N, Bogu GK, Bhinge A, Teng SW, Choo SH, et al. A genome-wide screen for genetic variants that modify the recruitment of REST to its target genes. PLoS Genet 2012; 8: e1002624.
39. Irier HA, Jin P. Dynamics of DNA methylation in aging and Alzheimer's disease. DNA Cell Biol 2012; 31(SUPPL. 1): S42-S48.
40. Chodavarapu RK, Feng S, Bernatavichute YV, Chen PY, Stroud H, Yu Y, et al. Relationship between nucleosome positioning and DNA methylation. Nature 2010; 466: 388-392.
41. Cokus SJ, Feng S, Zhang X, Chen Z, Merriman B, Haudenschild CD, et al. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 2008; 452: 215-219.
42. Mohn F, Weber M, Schubeler D, Roloff TC. immunoprecipitation (MeDIP). Methods Mol Biol 2009; 507: 55-64.
43. Zhu C, Yu ZB, Chen XH, Ji CB, Qian LM, Han SP. DNA hyper-methylation of the NOX5 gene in fetal ventricular septal defect. Exp Ther Med 2011; 2: 1011-1015.
44. Movassagh M, Choy MK, Goddard M, Bennett MR, Down TA, Foo RS. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One 2010; 5: e8564.
45. Haider S, Cordeddu L, Robinson E, Movassagh M, Siggens L, Vujic A, et al. The landscape of DNA repeat elements in human heart failure. Genome Biol 2012; 13: R90.
46. Haddad R, Kasneci A, Mepham K, Sebag IA, Chalifour LE. Ges-tational exposure to diethylstilbestrol alters cardiac structure/function, protein expression and DNA methylation in adult male mice progeny. Toxicol Appl Pharmacol 2013; 266: 27-37.
47. Metes-Kosik N, Luptak I, Dibello PM, Handy DE, Tang SS, Zhi H, et al. Both selenium deficiency and modest selenium supplementation lead to myocardial fibrosis in mice via effects on redox-meth-ylation balance. Mol Nutr Food Res 2012; 56: 1812-1824.
48. Movassagh M, Choy MK, Knowles DA, Cordeddu L, Haider S, Down T, et al. Distinct epigenomic features in end-stage failing human hearts. Circulation 2011; 124: 2411-2422.
49. Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-aza-cytidine. Interact Cardiovasc Thorac Surg 2007; 6: 593-597.
50. Ye NS, Chen J, Luo GA, Zhang RL, Zhao YF, Wang YM. Proteomic profiling of rat bone marrow mesenchymal stem cells induced by 5-azacytidine. Stem Cells Dev 2006; 15: 665-676.
51. Liang P, Song F, Ghosh S, Morien E, Qin M, Mahmood S, et al. Genome-wide survey reveals dynamic widespread tissue-specifc changes in DNA methylation during development. BMC Genomics 2011; 12: 231.
52. Mattick JS. Non-coding RNAs: The architects of eukaryotic complexity. EMBO Rep 2001; 2: 986-991.
53. Dorn GW Decoding the cardiac message: The 2011 Thomas W. Smith Memorial Lecture. Circ Res 2012; 110: 755-763.
54. van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles. Nat Rev Drug Discovery 2012; 11: 860-872.
55. Kawashima T, Shioi T. MicroRNA, emerging role as a biomarker of heart failure. Circ J 2011; 75: 268-269.
56. Song HK, Hong SE, Kim T, Kim do H. Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy. PLoS One 2012; 7: e35552.
57. Lee JH, Gao C, Peng G, Greer C, Ren S, Wang Y, et al. Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circ Res 2011; 109: 1332-1341.
58. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011; 25: 1915-1927.
59. Lee JT. Epigenetic regulation by long noncoding RNAs. Science 2012; 338: 1435-1439.
60. Grote P, Wittler L, Hendrix D, Koch F, Wahrisch S, Beisaw A, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell 2013; 24: 206-214.
61. Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell 2013; 152: 570-583.
62. Saha A, Wittmeyer J, Cairns BR. Chromatin remodelling: The industrial revolution of DNA around histones. Nat Rev Mol Cell Biol 2006; 7: 437-447.
63. Fazzio TG, Tsukiyama T. Chromatin remodeling in vivo: Evidence for a nucleosome sliding mechanism. Mol Cell 2003; 12: 1333-1340.
64. Boeger H, Griesenbeck J, Strattan JS, Kornberg RD. Removal of promoter nucleosomes by disassembly rather than sliding in vivo. Mol Cell 2004; 14: 667-673.
65. Bruno M, Flaus A, Stockdale C, Rencurel C, Ferreira H, Owen-Hughes T. Histone H2A/H2B dimer exchange by ATP-dependent chromatin remodeling activities. Mol Cell 2003; 12: 1599-1606.
66. Mizuguchi G, Shen X, Landry J, Wu WH, Sen S, Wu C. ATP-driven exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex. Science 2004; 303: 343-348.
67. Cairns BR. Chromatin remodeling: Insights and intrigue from single-molecule studies. Nat Struct Mol Biol 2007; 14: 989-996.
68. Armstrong JA, Papoulas O, Daubresse G, Sperling AS, Lis JT, Scott MP, et al. The Drosophila BRM complex facilitates global transcription by RNA polymerase II. EMBO J 2002; 21: 5245-5254.
69. Batsche E, Yaniv M, Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat Struct Mol Biol 2006; 13: 22-29.
70. Corey LL, Weirich CS, Benjamin IJ, Kingston RE. Localized recruitment of a chromatin-remodeling activity by an activator in vivo drives transcriptional elongation. Genes Dev 2003; 17: 1392-1401.
71. Morillon A, Karabetsou N, O'Sullivan J, Kent N, Proudfoot N, Mellor J. Isw1 chromatin remodeling ATPase coordinates transcription elongation and termination by RNA polymerase II. Cell 2003; 115: 425-435.
72. Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, Wolffe AP. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet 1999; 23: 62-66.
73. Kusch T, Florens L, Macdonald WH, Swanson SK, Glaser RL, Yates JR et al. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 2004; 306: 2084-2087.
74. Hakimi MA, Bochar DA, Schmiesing JA, Dong Y, Barak OG, Speicher DW, et al. A chromatin remodelling complex that loads cohesin onto human chromosomes. Nature 2002; 418: 994-998.
75. Huang J, Hsu JM, Laurent BC. The RSC nucleosome-remodeling complex is required for Cohesin's association with chromosome arms. Mol Cell 2004; 13: 739-750.
76. Han P, Hang CT, Yang J, Chang CP. Chromatin remodeling in cardiovascular development and physiology. Circ Res 2011; 108: 378-396.
77. Lei I, Gao X, Sham MH, Wang Z. SWI/SNF protein component BAF250a regulates cardiac progenitor cell differentiation by modulating chromatin accessibility during second heart feld development. J Biol Chem 2012; 287: 24255-24262.
78. Stankunas K, Hang CT, Tsun ZY, Chen H, Lee NV, Wu JI, et al. Endocardial Brg1 represses ADAMTS1 to maintain the microenvi-ronment for myocardial morphogenesis. Dev Cell 2008; 14: 298-311.
79. Lickert H, Takeuchi JK, Von Both I, Walls JR, McAuliffe F, Adamson SL, et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004; 432: 107-112.
80. Wang Z, Zhai W, Richardson JA, Olson EN, Meneses JJ, Firpo MT, et al. Polybromo protein BAF180 functions in mammalian cardiac chamber maturation. Genes Dev 2004; 18: 3106-3116.
81. Hang CT, Yang J, Han P, Cheng HL, Shang C, Ashley E, et al. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 2010; 466: 62-67.
82. Rottbauer W, Saurin AJ, Lickert H, Shen X, Burns CG, Wo ZG, et al. Reptin and pontin antagonistically regulate heart growth in ze-brafish embryos. Cell 2002; 111: 661-672.
83. Hurd EA, Capers PL, Blauwkamp MN, Adams ME, Raphael Y, Poucher HK, et al. Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm Genome 2007; 18: 94-104.
84. Lange M, Kaynak B, Forster UB, Tonjes M, Fischer JJ, Grimm C, et al. Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex. Genes Dev 2008; 22: 2370-2384.
85. Koda M, Takemura G, Okada H, Kanoh M, Maruyama R, Esaki M, et al. Nuclear hypertrophy reflects increased biosynthetic activities in myocytes of human hypertrophic hearts. Circ J 2006; 70: 710-718.
86. Nikolova V, Leimena C, McMahon AC, Tan JC, Chandar S, Jogia D, et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 2004; 113: 357-369.
87. van Steensel B, Dekker J. Genomics tools for unraveling chromosome architecture. Nat Biotechnol 2010; 28: 1089-1095.
88. Simonis M, Kooren J, de Laat W. An evaluation of 3C-based methods to capture DNA interactions. Nat Methods 2007; 4: 895-901.
89. Warren SA, Terada R, Briggs LE, Cole-Jeffrey CT, Chien WM, Seki T, et al. Differential role of Nkx2-5 in activation of the atrial natriuretic factor gene in the developing versus failing heart. Mol Cell Biol 2011; 31: 4633-4645.
90. Narlikar L, Sakabe NJ, Blanski AA, Arimura FE, Westlund JM, Nobrega MA, et al. Genome-wide discovery of human heart enhancers. Genome Res 2010; 20: 381-392.
91. He A, Kong SW, Ma Q, Pu WT. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci USA 2011; 108: 5632-5637.
92. Kodo K, Nishizawa T, Furutani M, Arai S, Ishihara K, Oda M, et al. Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects. Circ J 2012; 76: 1703-1711.
93. Sayed D, He M, Yang Z, Lin L, Abdellatif M. Transcriptional regulation patterns revealed by high resolution chromatin immunopre-cipitation during cardiac hypertrophy. J Biol Chem 2013; 288: 2546-2558.
94. Segal E, Widom J. What controls nucleosome positions? Trends Genet 2009; 25: 335-343.
95. Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res 2007; 17: 877-885.
96. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, et al. High-resolution mapping and characterization of open chromatin across the genome. Cell 2008; 132: 311-322.
97. Cui K, Zhao K. Genome-wide approaches to determining nucleo-some occupancy in metazoans using MNase-Seq. Methods Mol Biol 2012; 833: 413-419.
98. van Steensel B, Henikoff S. Identification of in vivo DNA targets of chromatin proteins using tethered dam methyltransferase. Nat Biotechnol 2000; 18: 424-428.
99. Xiao R, Moore DD. DamIP: Using mutant DNA adenine methyl-transferase to study DNA-protein interactions in vivo. Current protocols in molecular biology, 2011; Chapter 21: Unit 21.21.
100. de Wit E, Greil F, van Steensel B. Genome-wide HP1 binding in Drosophila: Developmental plasticity and genomic targeting signals. Genome Res 2005; 15: 1265-1273.
101. Zullo JM, Demarco IA, Pique-Regi R, Gaffney DJ, Epstein CB, Spooner CJ, et al. DNA sequence-dependent compartmentalization and silencing of chromatin at the nuclear lamina. Cell 2012; 149: 1474-1487.
102. Zhang Z, Wippo CJ, Wal M, Ward E, Korber P, Pugh BF. A packing mechanism for nucleosome organization reconstituted across a eukaryotic genome. Science 2011; 332: 977-980.
103. Chen H, Monte E, Parvatiyar MS, Rosa-Garrido M, Franklin S, Vondriska TM. Structural considerations for chromatin state models with transcription as a functional readout. FEBS Lett 2012; 586: 3548-3554.
104. Solovei I, Kreysing M, Lanctot C, Kosem S, Peichl L, Cremer T, et al. Nuclear architecture of rod photoreceptor cells adapts to vision in mammalian evolution. Cell 2009; 137: 356-368.
105. Ohtani K, Dimmeler S. Epigenetic regulation of cardiovascular differentiation. Cardiovasc Res 2011; 90: 404-412.
106. Udali S, Guarini P, Moruzzi S, Choi SW, Friso S. Cardiovascular epigenetics: From DNA methylation to microRNAs. Mol Aspects Med 2012 September 6, doi:10.1016/j.mam.2012.08.001 [Epub ahead of print].
107. Schonrock N, Harvey RP, Mattick JS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res 2012; 111: 1349-1362.
108. Mitchell-Jordan S, Chen H, Franklin S, Stefani E, Bentolila LA, Vondriska TM. Features of endogenous cardiomyocyte chromatin revealed by super-resolution STED microscopy. J Mol Cell Car-diol 2012; 53: 552-558.
109. Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, et al. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 2011; 14: 1345-1351.